Hepatotoxicty of Agents Used in the Management of Inflammatory Bowel Disease: a 2020 Update
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11894-020-00781-3.pdf
Reference109 articles.
1. Andrade RJ, Chalasani N, Björnsson ES, Suzuki A, Kullak-Ublick GA, Watkins PB, et al. Drug-induced liver injury. Nat Rev Dis Primers. 2019;5(1):58.
2. Yaccob A, Mari A. Practical clinical approach to the evaluation of hepatobiliary disorders in inflammatory bowel disease. Frontline Gastroenterology. 2019;10(3):309–15.
3. Khokhar OS, Lewis JH. Hepatotoxicity of agents used in the management of inflammatory bowel disease. Dig Dis. 2010;28(3):508–18.
4. • Lichtenstein GR, Loftus EV Jr, Isaacs KL, et al. ACG clinical guideline: management of Crohn’s disease in adults. Am J Gastroenterol. 2018;113(4):481–517 The most recent update on management of Crohns disease by the American College of Gastroenterology highlights how oral mesalamine should not be used for the treatment of active disease.
5. Ransford RA, Langman MJ. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. Gut. 2002;51(4):536–9.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Inflammatory Bowel Disease Therapies and Acute Liver Injury;Toxics;2024-06-08
2. The Natural History of Patients With Pre-Existing and De Novo Inflammatory Bowel Disease After Solid Organ Transplantation: EITOS Study of GETECCU;Inflammatory Bowel Diseases;2024-03-22
3. Mesalamine induced hepatotoxicity. Is mesalamine safe?;Revista Española de Enfermedades Digestivas;2024
4. Hepatotoxicity in inflammatory bowel disease: Immunomodulators, biologics, and beyond;Clinical Liver Disease;2024-01
5. Medikamentös-toxische Hepatopathie – eine unterschätzte Gefahr;DMW - Deutsche Medizinische Wochenschrift;2023-06-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3